Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Webmd Health Corp gives Q1 2014 earnings outlook; revenue outlook above analysts' estimates; gives FY 2014 outlook in line with analysts' estimates; announces increase in stock repurchase program


Monday, 10 Feb 2014 04:05pm EST 

Webmd Health Corp:Expects Q1 2014 revenue to be about $130-$133 mln.Expects Q1 2014 adjusted EBITDA to be about $28.5-$30.5 mln.Expects Q1 2014 net income as a percentage of revenue to be about 3 pct to 4 pct.Expects FY 2014 revenue to be about $545-$575 mln.Expects FY 2014 adjusted EBITDA to be about $140-$155 mln.Expects FY 2014 net income to be about $27-$39 mln.Q1 2014 revenue of $123 mln - Thomson Reuters I/B/E/S.FY 2014 revenue of $564 mln, EBITDA of $151 mln, net income of $27 mln - Thomson Reuters I/B/E/S.Says an increase of $50 mln in the amount available under its existing stock repurchase program.Says this increases the amount currently available for repurchases to about $70 mln.Says under the program, it may repurchase shares from time to time in the open market, through block trades or in private transactions, depending on market conditions and other factors. 

Company Quote

50.04
0.1 +0.20%
22 Jul 2014